← Browse by Condition
Medical Condition
primary immune thrombocytopenia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06658834 Phase 2
Recruiting
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Enrollment
129 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT07039422 Phase 2
Recruiting
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
Enrollment
60 pts
Location
Belgium, China, Czec...
Sponsor
Novartis Pharmaceuticals